Zingiber officinale
Species
KNApSAcK Entry
| Organism name | Zingiber officinale |
|---|---|
| Genus | Zingiber |
| Family | Zingiberaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Zingiber officinale |
|---|---|
| Linked NCBI taxonomy ID | 94328 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Zingiberaceae |
|---|---|
| ID | 4642 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | Liliopsida |
|---|---|
| ID | 4447 |
Metabolite list (47)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00003672
|
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
|
||
|
C00030345
|
gamma-Cadinene
|
C054278
|
No. 283 | No. 39 |
|
|||
|
C00029671
|
alpha-Muurolene
|
No. 283 | No. 39 |
|
||||
|
C00003106
|
beta-Cadinene
|
No. 283 | No. 39 |
|
||||
|
C00002748
|
[6]-Gingerol
/ (S)-6-Gingerol / (S)-(+)-[6]Gingerol |
CHEMBL402978
CHEMBL1950582 |
4 / 4 / 0 | No. 293 | No. 32 |
|
||
|
C00002764
|
[6]-Paradol
|
CHEMBL2071440
|
C421614
|
No. 293 | No. 32 |
|
||
|
C00002774
|
[6]-Shogaol
|
CHEMBL25948
|
C040115
|
8 / 3 / 4 | 10 / 1 | No. 293 | No. 32 |
|
|
C00035687
|
Methyl [6]-paradol
|
No. 293 | No. 32 |
|
||||
|
C00035450
|
[8]-Paradol
|
No. 293 | No. 32 |
|
||||
|
C00035688
|
Methyl [6]-Shogaol
|
No. 293 | No. 32 |
|
||||
|
C00002746
|
[6]-Gingerdione
|
C050872
|
No. 293 | No. 32 |
|
|||
|
C00035448
|
[7]-Gingerol
|
No. 293 | No. 32 |
|
||||
|
C00035447
|
[6]-Gingerdiol
|
CHEMBL2071441
CHEMBL2071442 |
No. 293 | No. 32 |
|
|||
|
C00035689
|
Methyl [8]-Shogaol
|
No. 293 | No. 32 |
|
||||
|
C00035446
|
[4]-Shogaol
|
CHEMBL277440
|
No. 293 | No. 32 |
|
|||
|
C00035445
|
[4]-Isogingerol
|
No. 293 | No. 32 |
|
||||
|
C00035444
|
[4]-Gingerol
|
No. 293 | No. 32 |
|
||||
|
C00035443
|
[12]-Shogaol
|
CHEMBL24703
|
No. 293 | No. 32 |
|
|||
|
C00035442
|
[10]-Gingerdiol
|
No. 293 | No. 32 |
|
||||
|
C00031474
|
(S)-10-Gingerol
/ (+)-(S)-[10]-Gingerol |
CHEMBL549472
|
2 / 2 / 0 | No. 293 | No. 32 |
|
||
|
C00003118
|
Copaene
/ alpha-Copaene / (-)-alpha-Copaene |
No. 333 | No. 38 |
|
||||
|
C00048313
|
alpha-Curcumene
|
CHEMBL469717
|
C086829
|
No. 456 | No. 38 |
|
||
|
C00003122
|
(S)-(+)-Curcumene
/ (S)-alpha-Curcumene |
CHEMBL469717
|
No. 456 | No. 38 |
|
|||
|
C00003028
|
Borneol
/ (+/-)-Borneol |
CHEMBL296404
CHEMBL486208 CHEMBL1097205 CHEMBL1968981 |
8 / 5 / 1 | No. 649 | No. 35 |
|
||
|
C00029674
|
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
|
|
|
C00011067
|
Tricyclene
/ Teresantanane |
No. 1225 |
|
|||||
|
C00003036
|
Neral
/ Citral Z |
CHEMBL1080997
|
6 / 7 / 9 | No. 1575 | No. 34 |
|
||
|
C00035469
|
1-Dehydro-[10]-gingerdione
|
No. 1634 |
|
|||||
|
C00044042
|
[6]-Dehydroshogaol
|
No. 1634 |
|
|||||
|
C00035471
|
1-Dehydro-[8]-gingerdione
|
No. 1634 |
|
|||||
|
C00044041
|
[10]-Dehydroshogaol
|
No. 1634 |
|
|||||
|
C00035470
|
1-Dehydro-[6]-gingerdione
|
No. 1634 |
|
|||||
|
C00047685
|
6-Dehydrogingerdione
|
No. 1634 |
|
|||||
|
C00035640
|
Hexahydrocurcumin
|
CHEMBL479650
|
1 / 2 / 0 | No. 1938 | No. 21 |
|
||
|
C00002747
|
Gingerenone A
|
CHEMBL1086746
|
No. 1938 | No. 21 |
|
|||
|
C00011968
|
Sesquisabinene hydrate
|
No. 1968 |
|
|||||
|
C00011604
|
Zingiberenol
|
No. 2213 |
|
|||||
|
C00003204
|
l-Zingiberene
/ (-)-Zingiberene / alpha-Zingiberene |
CHEMBL479020
|
No. 2380 | No. 38 |
|
|||
|
C00007630
|
beta-Sesquiphellandrene
|
CHEMBL469718
|
No. 2380 | No. 38 |
|
|||
|
C00000839
|
3-Carene
|
CHEMBL506854
|
C030218
|
No. 2690 | No. 35 |
|
||
|
C00011967
|
Sesquithujene
|
No. 2854 |
|
|||||
|
C00035577
|
Diacetoxy-4-gingerdiol
/ Diacetoxy-[4]-gingerdiol |
No. 3158 |
|
|||||
|
C00035449
|
[8]-Gingerdiol
|
No. 3158 |
|
|||||
|
C00035513
|
Acetoxy-10-gingerol
/ Acetoxy-[10]-gingerol |
No. 3158 |
|
|||||
|
C00035574
|
Dehydrogingerdione
|
CHEMBL211958
|
1 / 0 / 0 | No. 4323 |
|
|||
|
C00034775
|
6-Methyl-5-hepten-2-one
|
CHEMBL46340
|
C029750
|
No. 5297 |
|
|||
|
C00000136
|
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
|
Human Protein / Gene in interactions
127 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P08183 | Multidrug resistance protein 1 | drug | C00002748 C00002774 C00003672 C00031474 | 1 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00002774 C00003672 | 0 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00002774 C00003672 | 1 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00002748 C00002774 C00031474 | 1 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00003672 | 1 / 1 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00003028 C00029674 | 5 / 1 |
| P10275 | Androgen receptor | NR3C4 | C00000136 C00003036 | 3 / 4 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00002774 | 0 / 3 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002748 C00003672 | 2 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000136 C00003672 | 1 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00003672 | 0 / 0 |
| Q8NER1 | Transient receptor potential cation channel subfamily V member 1 | TRPV (Vanilloid) | C00002748 C00002774 | 0 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00002774 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00003672 | 0 / 1 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00003028 C00029674 | 3 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00003672 | 3 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00029674 | 11 / 10 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 | 0 / 0 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000136 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00003036 | 3 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000136 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000136 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000136 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00000136 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
| P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00003028 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 1 / 8 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 | 2 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00003672 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00003036 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00000136 | 0 / 0 |
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00003028 | 0 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00003028 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000136 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 | 1 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000136 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 | 1 / 0 |
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003036 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000136 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000136 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000136 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 | 0 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 | 0 / 0 |
| P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00003028 | 0 / 0 |
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00003028 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000136 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00000136 | 2 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000136 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000136 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 | 0 / 0 |
| P26358 | DNA (cytosine-5)-methyltransferase 1 | Transferase | C00035640 | 2 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 | 0 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 | 2 / 2 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 | 0 / 0 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002774 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 | 4 / 3 |
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00003028 | 0 / 0 |
| Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000136 | 0 / 1 |
| Q04760 | Lactoylglutathione lyase | Enzyme | C00035574 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 | 0 / 0 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003036 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003036 | 1 / 4 |
10 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002774
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002774
|
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002774
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002774
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002774
|
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002774
|
| 1676 | DFFA, DFF-45, DFF1, ICAD | DNA fragmentation factor, 45kDa, alpha polypeptide |
C00002774
|
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002774
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002774
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002774
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (82)
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn |
P26358
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #614116 | Neuropathy, hereditary sensory, type ie; hsn1e |
P26358
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601367 | Stroke, ischemic |
P00734
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (62)
| KEGG | name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|